Tumor regression caused by cps therapy is associated with high‐level expression of T‐cell receptor costimulatory molecules CD80 and CD86 and IL‐12 and IFN‐γ, which are crucial for activating antitumor T‐cell immunity. The gene discussed is CD86; the disease is neoplasm.